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Appetite control and satiety mechanisms help animals maintain energy homeostasis; 
however, these mechanisms can be misregulated, leading to overweight and obesity. 
Caenorhabditis elegans is an excellent model system to study appetite and satiety 
because of its conserved behavioral aspects of satiety and conserved molecular 
mechanisms. ASI senses nutrition and its activity is required for the behavioral state of 
satiety quiescence. The purpose of this thesis project was to elucidate the function of 
cGMP signaling in ASI by looking at behavioral effects from the pharmacological use of 
sildenafil (Viagra), a PDE inhibitor, and the effects on ASI activation from mutating 
guanylyl cyclase DAF-11. Sildenafil treatment increases satiety quiescence and decreases 
fat storage in a PDE-dependent manner. The daf-11 mutation decreased overall 
	  
 
fluorescence intensity of ASI activation and the frequency at which ASI activated by 
about 50% compared to wild-type worms, suggesting that DAF-11 plays an important 
role in ASI to promote satiety.
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Chapter 1 Introduction 
 
1.1 Importance of understanding appetite control in the context of the obesity epidemic  
 
In 2008, more than 1.4 million adults were overweight and more than half a 
billion were obese worldwide. Approximately 2.8 million people die year globally from a 
complication of being overweight or obese1, such as heart disease, stroke, type 2 diabetes, 
and certain types of cancer, which are some of the leading causes of preventable death.  
In the United States alone, $147 billion were spent in estimated medical costs in 2008, 
and individuals who are obese spent an average of $1,429 more in medical care than 
those who are not obese2.  
The factors contributing to body weight are complex and involve a combination 
of an individual’s genetics and environment, but body weight is ultimately a result of the 
body’s balance of energy and caloric intake. Animals naturally have appetite control and 
satiety mechanisms in place in order to maintain energy homeostasis. However, these 
mechanisms can be misregulated, which can lead to eating over the daily caloric 
requirement, energy imbalance, and subsequent weight gain. The importance of 
understanding appetite control and satiety continues to be more pressing with the steady 
rise of the global obesity epidemic.  
 
 
 
	  
  2 
 
1.2 What is satiety? 
 
Satiety is the feeling of fullness that results in the cessation of feeding, and is a 
complex, yet widely conserved behavior in many animals. A series of satiety behaviors 
have been reported and repeatedly observed in many animals, including mice, rhesus 
monkeys, human infants; upon feeling full, the animal stops eating, grooms and explores 
for some time, and then rests3. These behaviors are a result of many integrated signaling 
molecules and neuronal networks in order for an animal to maintain proper energy 
homeostasis4.  
In mammals, satiety results from various signals from the gut and adipose tissue 
relaying and converging at multiple levels of the central nervous system. Neuropeptides, 
such as cholecystokinin (CCK) released from the gut in response to dietary nutrients, 
enter the brain directly from circulation, or its signal is input at vagal afferents 
innervating the viscera and gastrointestinal tract, which then connect to higher brain 
centers4–6. Mechanoreceptors are also present on vagal afferents that are located on 
branches lining the gastrointestinal tract, which are sensitive to stomach and intestinal 
volume and pressure4. Signaling from all levels is then integrated in the hypothalamus 
and brainstem, which then interact with higher brain centers to terminate meals, including 
reward centers such as the ventral tegmental area and nucleus accumbens, and areas 
involved in executive decision making such as the prefrontal cortex4,5.  
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1.3 C. elegans as a powerful model for studying satiety  
 
Although knowledge about satiety signals has increased dramatically within the 
past 50 years, many details of the molecular and neuronal mechanisms by which satiety is 
signaled remain unclear. The largest obstacle in studying appetite and satiety in mammals 
is the degree of complexity that is encountered and a vast number of technical limitations. 
With trillions of connections among billions of neurons, it is an especially difficult 
endeavor to study detailed neuromolecular mechanisms underlying appetite control in 
mammals.  
Interestingly, many aspects of the appetite-controlling behavior and of the 
molecular pathways are conserved7–9 in a simpler organism, the Caenorhabditis elegans, 
a small, free-living soil nematode. Worm behavior after feeding mimics behavioral 
aspects of satiety and postprandial sleep in mammals. Additionally, satiety signaling in C. 
elegans is partly regulated through a TGF-β and cGMP (cyclic guanosine 
monophosphate) pathway that is also conserved in mammals10.  
In addition to conserved behavior and mechanisms, the simplicity of the nervous 
system of C. elegans makes it a great model to use in order to study neuronal 
mechanisms of appetite control. C. elegans only has 302 neurons and is the only 
organism whose entire neural network is mapped by EM reconstruction.  
Furthermore, using C. elegans as a model presents numerous other conveniences. 
C. elegans are self-fertilizing hermaphrodites (with about 0.02% existing as males 
through the non-disjunction of the sex chromosome during meiosis). The life cycle period 
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from egg to adult is about 3 days, with each worm laying about 300 eggs, which allow 
large numbers of worms to be bred cheaply, easily, and quickly. The worm is transparent 
under the microscope, which allows for many accessible techniques and assays. C. 
elegans is also a powerful genetic model because they are amenable to genetic 
manipulation. The haploid genome size is only 100 megabase pairs (Mb)11, compared to 
about 3,200 Mb in humans12,13. DNA can be injected directly into the gonad of the worm 
under a microscope to create transgenic worms and RNA interference knockdown of 
gene expression to assess the role of genes can be accomplished simply by feeding them 
bacteria that expresses the RNAi of choice. Through the study of a much simpler model 
organism such as C. elegans, the core molecular basis of the appetite-controlling behavior 
can still be unraveled without the complexity that come with mammalian models.  
 
1.4 Feeding and satiety behaviors in C. elegans 
 
C. elegans primarily feeds on bacteria. It pumps food through a large pharynx, 
and the food is crushed as it passes into the intestine. C. elegans actively seek out food 
depending on the food quality, which is defined as its ability to support growth, and 
visibly prefer high quality food. Worms switch between two modes of movement when 
seeking for good food—dwelling and roaming. Dwelling is low-speed movement with 
frequent stops and backing up in the reverse direction in a restricted area. Roaming is 
rapid straight movement, which is common on bad quality food as the worm continues to 
search for better food14.  
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A third behavioral state in worms, called satiety quiescence, is the cessation of all 
feeding and movement. The development of quiescence seems to resemble the sequence 
of mammalian satiety behaviors and is a sleep-like state that results from being satiated. 
It depends on food quality, requires nutritional signals from the intestine, and is affected 
by previous feeding history; for example, fasting before refeeding enhances quiescence10.   
 
1.5 Neuronal and molecular regulation of satiety in C. elegans 
 
Although not all details are known, it is clear that a simple neuronal circuit 
consisting of a cGMP (cyclic guanylyl monophosphate) molecular pathway and a TGF-β 
molecular pathway is involved to signal postprandial satiety. ASI, a pair of amphid 
neurons in the head of C. elegans, responds to nutritional cues in the environment and is 
part of the neural circuit that ultimately signals postprandial satiety. Worms lacking ASI 
do not show satiety quiescence and spend more time roaming in search of food15. ASI 
also regulates the worm’s developmental choices depending on the worm’s nutritional 
environment; under an adverse condition such as starvation, C. elegans larvae enter a 
dormant developmental stage called the dauer larva to prolong its life span16. Without 
ASI, the worm frequently enters dauer formation17 even in a food-rich environment, 
suggesting that the ASI is important for sensing nutrients.   
Satiety quiescence requires intact cGMP signaling in ASI10,15. cGMP is an 
important second messenger in a variety of mammalian cell signaling processes, such as 
blood pressure18, reproduction19, phototransduction in the eyes20,21, circadian rhythms22, 
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and intestinal homeostasis7, and body size regulation and exploratory behavior in 
invertebrates23. This cGMP pathway is also conserved in mammalian appetite control 
systems24. The C. elegans genome contains 34 guanylate cyclases (GCY), including 27 
membrane-bound and 7 soluble GCYs. The soluble GCYs are expressed in sensory 
neurons and not required for satiety quiescence (personal communication, Young-Jai 
You). Of the 27 membrane-bound GCYs, 3 of them are known to be important for satiety 
quiescence: DAF-11, GCY-18, and GCY-28. Previous data show that a worm goes into 
satiety quiescence, possibly by ASI activation when food is replaced with 8-Br-cGMP (a 
membrane-permeant form of cGMP), even in the absence of food. Furthermore, the 
addition of 8-Br-cGMP brings a worm out of its dauer phase and rescues satiety 
quiescence in animals deficient in certain GCYs. This suggests that a GCY may be 
directly involved in receiving nutrient signals from the worm’s environment, or at least 
act downstream of the nutrient signal. Further investigation is required in order to 
validate the role of these GCYs and cGMP in the activation of ASI.   
Suspected to act downstream of cGMP is a Transforming Growth Factor-β (TGF-
β) superfamily member called DAF-7. TGF-β signaling has recently been implicated in 
mammalian weight25, appetite26, and fat mobilization27, and has been extensively studied 
in other systems such as cell proliferation, differentiation, and tumor formation in 
mammals28. Once ASI is activated, DAF-7 is expressed in ASI and is released10,29. It was 
also shown that daf-7 expression in ASI is dependent on DAF-1130, suggesting cGMP 
acts upstream of DAF-7 expression. Worms lacking DAF-7 show a decrease in satiety 
quiescence, similar to ASI-ablated worms. Additionally, upon treatment with 8-Br-cGMP 
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rather than food, daf-7 expression is enhanced, suggesting further that cGMP release 
follows ASI receiving the nutrition signal which is then followed by daf-7 expression. 
The mechanistic details between the formation of cGMP and daf-7 expression are not 
entirely known, but it is suspected that cGMP signals through a combination of cyclic 
nucleotide gated channels (CNGs), such as that formed by TAX-2 and TAX-4 subunits, 
and cGMP-dependent protein kinases (PKGs), namely EGL-4, to upregulate the 
expression of daf-710,31.  
Intracellular cGMP would be degraded by phosphodiesterases (PDEs) to turn off 
the signal after cGMP action is completed. The C. elegans genome encodes six different 
PDEs, PDE-1 through 6, and each is known to have a closely related human homolog. 
PDE-1, 2, 3, and 5 cleave cGMP, while PDE-4 and PDE-6 are specific for cAMP20. It is 
unclear whether and how the inhibition of PDEs and therefore an increase in intracellular 
cGMP levels would affect satiety.  
RIM is a pair of motor neurons and RIC is a pair of interneurons also in the head 
of the worm that have been shown to be involved in hunger. Following expression, DAF-
7 is released from ASI and binds with TGF-β receptor DAF-1 on RIM and RIC to inhibit 
the action of RIM and RIC neurons16. This inhibition of RIM and RIC then may 
subsequently allow the worm to go into satiety quiescence. When RIM and RIC were 
ablated in daf-7 mutants, the quiescence defect of daf-7 mutants in satiety was rescued, 
suggesting that RIM and RIC act downstream of DAF-7 to antagonize DAF-7 function15.   
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1.6 Experimental approach and hypothesis: 
 
The molecular mechanisms by which cGMP signaling regulates appetite are still 
unclear. In this project, we focused on the cGMP signaling pathway and its role in ASI 
activation that eventually leads to satiety quiescence. In order to examine the function 
and importance of cGMP signaling in ASI in controlling feeding and satiety behaviors, 
we used sildenafil (Viagra), a commercially available PDE inhibitor, to increase 
intracellular level of cGMP. Sildenafil occupies the same Q pocket that cGMP binds to 
human PDE-532. There is also high sequence homology between the human PDE-5 Q 
pocket and that of C. elegans PDEs that bind cGMP32 (personal communication, Young-
Jai You), suggesting that sildenafil will also competitively inhibit C. elegans PDEs. We 
predicted that through the competitive inhibition of PDEs by sildenafil and blocking the 
degradation of cGMP, levels of cGMP in ASI would potentially be increased and ASI 
would be activated, subsequently increasing satiety quiescence, decreasing food intake, 
and consequently decreasing worm fat stores.  
DAF-11 is one of the transmembrane GCYs previously shown to be important for 
satiety quiescence10 and is known to be expressed in ASI, along with at least four other 
amphid neurons33. ASI specific expression of DAF-11 in daf-11 mutants rescued the 
satiety quiescence defect of daf-11, showing that ASI is the action site of DAF-11 in 
satiety quiescence. In order to investigate whether a GCY is required for ASI activation, 
DAF-11 was chosen as the first candidate to test. It was hypothesized that ASI in daf-11 
mutants would not activate even with the presentation of nutrient-rich stimulus such as 
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Luria broth (LB), because we predicted that DAF-11 acts downstream of the nutrient 
signal.  
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Figure 1. Proposed model of ASI activation with cGMP signaling and TGF-β 
signaling pathways 
ASI senses a nutrient signal, possibly by a GCY. cGMP is formed which subsequently 
interacts with members of the TGF-β pathway, which inhibit RIM/RIC to stop the hunger 
signals and the worm can go into satiety quiescence. Once produced by a GCY, cGMP is 
degraded by PDEs.  
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Chapter 2 Materials and Methods 
 
2.1 General methods and worm strains 
 
Worms were grown and handled as described previously34, except worms were 
maintained on NGMSR plates35. All worms were maintained at 20°C on Escherichia coli 
strain HB101 unless indicated otherwise. The wild-type strain was C. elegans variant 
Bristol, strain N2. Mutant strains used were TQ1828 pde-1(nj57) pde-5(nj49) I; pde-
3(nj59) II; pde-2(tm3098) III, RB2279 pde-5(ok3102) I, and daf-11(jt195).  
 For synchronizing L1 larvae, worms on stock plates were washed and bleached as 
described previously36, then harvested eggs were rocked in M9 buffer overnight at 20°C. 
Newly hatched L1 larvae were transferred onto plates seeded with Escherichia coli strain 
HB101.  
 
2.2 Food intake assay 
 
Food intake was measured as described previously10 but including steps to treat plates 
with sildenafil. One colony of E. coli strain HB101 and one colony of E. coli HB101 
expressing fluorescent mCherry protein were separately inoculated in 50 ml LB each and 
grown overnight at 37°C, and then seeded on 60 mm NGMSR plates, which were then 
incubated overnight at 37°C. Plates were stored at room temperature for at least one 
night. The seeded 60 mm NGMSR plates were treated with 100 µl of dimethyl sulfoxide 
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(DMSO) for control worms or 100 µl of 400 µM sildenafil for experimental worms, so 
that DMSO was no more than 1% of agar volume and the final concentration of sildenafil 
is 20 µM. Treated plates are left to dry overnight at room temperature. L4 worms were 
picked to treated plates seeded with HB101, placed in a dark chamber that stays 
undisturbed on the countertop at 25°C and given 24 hours to develop into adults. At 24 
hours, the worms are transferred to treated plates seeded with mCherry HB101 and are 
left undisturbed for 1 hour, then treated with 100 µl of 1M sodium azide to fix their 
feeding status. Worms were mounted on 3% agar pads on glass slides and observed with 
a Zeiss Axio A2 Imager microscope with a 10X objective lens. Images were acquired 
using Zeiss Axiovision software and fluorescence was quantified using ImageJ software. 
For food intake assays done in conjunction with locomotion assays, each worm was 
treated with 5 µl of 1 M sodium azide to fix its feeding status at the end of the assay and 
imaged. 
 
2.3 Locomotion monitoring assay 
 
Locomotion was monitored and recorded in non-fasted conditions as described 
previously15, but including steps to treat plates with sildenafil and changing the volume of 
the mCherry bacteria suspension. 35 mm NGMSR plates were treated with 25 µl of 
DMSO and 25 µl of 400 µM sildenafil, and left to dry overnight at room temperature. 
The mCherry bacteria suspension was prepared as described previously15. On the day of 
the locomotion assays, 3 µl of prepared mCherry bacteria suspension was pipetted onto a 
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treated 35 mm NGMSR plate and allowed to dry completely. Adult worms that were 
transferred to treated HB101 plates 24 hours prior are transferred singly to individual 
plates prepared for locomotion assays.  
 
2.4 Oil-Red-O Staining 
 
60 mm NGMSR plates were seeded with E. coli strain HB101 and treated with 
DMSO and sildenafil as described above for food intake assays. L4 worms were picked 
and transferred to seeded plates, placed in a dark chamber that stays undisturbed on the 
countertop at 25°C, and given 24 hours to develop into adults. Then the worms were 
washed and stained with Oil-Red-O stain as previously reported37, except that worms 
were grown on the drug-treated plates and the freeze-thaw cycle steps were omitted. 
Worms were mounted on 3% agar pads on glass slides and observed with a Zeiss Axio 
A2 Imager microscope with a 10X objective lens. Images were acquired using Zeiss 
Axiovision software and the intensity of the red stain was quantified using ImageJ 
software. 
 
2.5 Calcium imaging 
 
60 mm NGMSR plates seeded with E. coli strain HB101 were treated with 600 µl 
of 20 mM 8-Br-cGMP (Sigma-Alrich) so that the final concentration of 8-Br-cGMP is 1 
mM. Treated plates are left to dry to 1 hour. daf-11 dauer worms with the GCaMP 
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transgene expressed in ASI were picked under fluorescence to sort transgenic worms, 
transferred to a 8-Br-cGMP treated plate (~20-30 worms per plate), and grown for 48 
hours at 15°C. Calcium imaging experiments were done as previously reported15 with 1-
day old adult daf-11 worms, using Luria broth (LB) as the stimulus.  
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Chapter 3 Results and Discussion 
 
3.1 Sildenafil increases satiety quiescence 
 
To examine how an increase of intracellular cGMP levels would affect satiety 
quiescence, a locomotion monitoring assay was done on wild-type worms on plates 
treated with DMSO and 20 µM sildenafil as described in Materials and Methods. The 
assay showed that sildenafil increased the time each worm spent in satiety quiescence, to 
almost double the time that worms spent in satiety quiescence in control conditions 
(Figure 2).  
 
3.2 Sildenafil decreases fat storage 
  
The increase of satiety quiescence by sildenafil treatment suggests that sildenafil 
reduces food intake, and subsequently fat storage. To test this idea, Oil-Red O staining 
was done on wild-type worms treated with DMSO and sildenafil for 24 hours as 
described in Materials and Methods. Stain intensity was analyzed with ImageJ. The 
average stain intensity of sildenafil-treated worms was significantly lower (p = 0.00007) 
than the DMSO-treated worms, indicating that sildenafil-treated worms had lower fat 
stores (Figure 3B).  
In order to confirm sildenafil’s action to increase intracellular cGMP levels via 
the competitive inhibition of PDEs, Oil-Red O staining was also done using PDE 
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mutants. First, worms containing mutations in all PDEs specific for cGMP were used20. 
Quadruple mutants of pde-5 pde-1; pde-3; pde-2 were treated under the same conditions 
as wild-type worms and the stain intensity was compared. There was no significant 
difference between the average stain intensities of DMSO- and sildenafil-treated mutants 
(Figure 4B). The experiment was repeated with pde-5 single mutant worms and again, 
there was no significant difference between the two groups (Figure 5B). These results 
show that sildenafil decreases fat storage by increasing intracellular cGMP levels in a 
PDE-dependent manner.  
 
3.3 Sildenafil effect in food intake 
 
Sildenafil decreases fat storage, which suggests that sildenafil reduces food intake. 
To test how an increase of intracellular cGMP levels would affect a worm’s food intake, 
the food intake of wild-type worms was measured after being treated on DMSO and 
sildenafil for 24 hours as described in Materials and Methods. The fluorescence intensity 
from E. coli strain HB101 expressing mCherry protein was analyzed with ImageJ. The 
average fluorescence intensity between DMSO and sildenafil-treated worms was not 
significantly different (Figure 6B). However, this may be explained by various technical 
reasons and limitations of the food intake assay, as will be discussed in further detail in 
the Discussion section.  
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3.4 Guanylate cyclase DAF-11 is important for ASI activation  
 
DAF-11 expressed in ASI is important for satiety quiescence10. To directly test whether 
DAF-11 is necessary for ASI activation, ASI activity of daf-11 mutant worms was 
recorded via calcium imaging as described in Materials and Methods. The individual 
traces were normalized (before the presentation of stimulus) so that the mean for the first 
15 s is 1, and then averaged. ASI in daf-11 mutant worms did show activation, but at a 
much lower overall fluorescence intensity compared to wild-type worms (Figures 7A and 
7B) and with ASI activation at about a 45% frequency compared to 100% frequency in 
wild-type worms (Figure 7C). This suggests that though DAF-11 is clearly important for 
full ASI activation, its functional role in activation is still unknown.  
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Figure 2. Sildenafil increases satiety quiescence  
Wild-type worms were treated with DMSO and sildenafil starting from L4 stage. After 24 
hours of treatment, their locomotion was recorded using the motion tracking system as 
described in Materials and Methods. Treatment with sildenafil significantly increased 
satiety quiescence. Control: n = 15, sildenafil: n = 28.  
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Figure 3. Sildenafil decreases fat storage in wild-type worms 
A) Wild-type worms were treated with DMSO and sildenafil starting from L4 stage. 
After 24 hours of treatment, worms were washed from the plate, stained with Oil-red O 
stain, and imaged. B) The stain intensities of the images were measured and averaged. 
Treatment with sildenafil significantly decreased fat storage (p = 0.000072).  
Control: n = 20, sildenafil: n = 20. 
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Figure 4. Sildenafil has no effect on fat storage in pde-5 pde-1; pde-3; pde-2 mutants 
A) Quadruple pde mutant worms (pde-5 pde-1; pde-3; pde-2) were treated with DMSO 
and sildenafil starting from L4 stage. After 24 hours of treatment, worms were washed 
from the plate, stained with Oil-red O stain, and imaged. B) The stain intensities of the 
images were measured and averaged. Treatment with sildenafil had no effect on fat 
storage (p = 0.298783). Control: n = 40, sildenafil: n = 40. 
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Figure 5. Sildenafil has no effect on fat storage in pde-5 mutants 
A) pde-5 mutant worms were treated with DMSO and sildenafil starting from L4 stage. 
After 24 hours of treatment, worms were washed from the plate, stained with Oil-red O 
stain, and imaged. B) The stain intensities of the images were measured and averaged. 
Treatment with sildenafil had no effect on fat storage (p = 0.323411). Control: n = 25, 
sildenafil: n = 25. 
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Figure 6. Sildenafil effect on food intake 
A) Wild-type worms were treated with DMSO and sildenafil starting from L4 stage. 
After 24 hours of treatment, their food intake was fixed with sodium azide and the worms 
were imaged. B) The fluorescence intensities of the images were measured and averaged. 
There was no significant difference between the control and sildenafil groups.  
Control: n = 25, sildenafil: n = 25. 
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Figure 7. Decreased intensity and frequency of ASI activation in daf-11 mutants 
daf-11 dauers were treated with 8-Br-cGMP for 48 hours to bring them out of the dauer 
stage and transferred off 8-Br-cGMP to be grown to adults. Worms were loaded into 
microfluidic devices and ASI activation was recorded via calcium imaging as described 
in Materials and Methods, using LB as the stimulus. A) ASI activation in control worms 
(n= 9), B) ASI activation in daf-11 mutants (n = 9), and C) the frequency of ASI 
activation in control worms and daf-11 mutants (control n = 9, daf-11 n = 9). 
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3.5 Discussion  
 
 Appetite control and satiety mechanisms are crucial for an animal to maintain 
healthy energy homeostasis. cGMP signaling has been previously shown to be involved 
in C. elegans satiety and its role was further confirmed with the progression of this 
project. In support of the hypothesis, treatment with sildenafil did increase satiety 
quiescence and decreased fat storage, possibly by increasing intracellular cGMP levels 
through its inhibition of PDEs. However, it is not known whether sildenafil acts solely in 
ASI, which can be addressed by targeting the expression of PDE-5 only in ASI and 
testing whether this will rescue the sildenafil effect in fat storage. Also, if sildenafil is 
increasing satiety by its inhibition of PDEs, then it is expected for the fat content of the 
PDE mutants to look similar to the lower fat content shown in sildenafil-treated wild-type 
worms. However, the fat content of the PDE mutants resembled the higher fat content of 
the control wild-type worms. The reasons for this discrepancy are unclear, but one 
possible explanation could be the differences in the length of time that the worms do not 
have PDE, as the PDE mutants do not have PDEs their entire lifetime and could have 
adapted to this condition, whereas the PDEs of sildenafil-treated wild-type worms are 
inhibited for only 24 hours. Another explanation could be variations in staining between 
the control and the PDE mutant experiments. Possible future experiments to resolve this 
discrepancy are described below in the Future Directions section.  
 Though the food intake assays did not show any significant differences in food 
intake between control and sildenafil-treated worms, sildenafil-treated worms showed 
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decreased fat storage. This may be due to unknown side effects of the drug or it could 
possibly be from decreasing food intake, which may not have been captured properly due 
to technical limitations of the assay. The assay is only a snapshot of fluorescence from 
the ground bacteria in the worm gut at the time of fixation with sodium azide, which is 
not a direct reflection of cumulative food intake or frequency of pharynx pumping 
(=feeding rate). It also does not account for any defecation cycles that may have changed, 
so fluorescent protein may be retained in the gut longer. This is why the staining of the 
worm’s fat stores can be considered to be a better reflection of the long-term effects of 
sildenafil treatment on energy balance. 
cGMP signaling seems to be downstream of ASI receiving a nutrient signal 
because exogenous 8-Br-cGMP mimics the effect of food. Also, 3 GCYs were found to 
be important for satiety quiescence, including DAF-11. For this reason, it was 
hypothesized that a GCY is involved in detecting the nutritional signal in the ASI, and 
mutating DAF-11 would abolish ASI response to LB. Although the daf-11 mutation did 
not fully eliminate ASI activation, it did decrease the overall fluorescence intensity and 
the frequency at which ASI activated by about 50% compared to wild-type worms. This 
indicates that DAF-11 does have a significant role in ASI activation, but the degree of its 
importance is not yet clear. It is possible that some biological redundancy exists for daf-
11 as there are other GCYs that are important for satiety quiescence.  There could also be 
redundancy at the neural circuit level; ASI is connected to the neuron AIA by gap 
junctions, which could also receive nutritional signals from other neurons and be 
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involved in activation of ASI. It is possible that in daf-11 mutants, AIA can be activated 
by nutrients, and that signal indirectly activates ASI less reliably and to a lesser degree.   
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Chapter 4 Conclusions and Future Directions 
 
4.1 Conclusions 
 
From the results of this project, it can be concluded that a cGMP signaling 
pathway is involved in ASI activation and satiety quiescence. Sildenafil increases satiety 
quiescence and decreases worm fat stores in a PDE-dependent manner, potentially by 
increasing intracellular cGMP levels through its competitive inhibition of PDEs. Finally, 
DAF-11 seems to have an important role in mediating ASI activation, though the exact 
function or the extent of its role in ASI is still unclear. It will be interesting to continue to 
illuminate more details about the cGMP signaling pathway in ASI in the endeavor to 
construct a more holistic understanding of appetite control and satiety.   
 
4.2 Future Directions 
 
In order to eliminate questions about whether the actions of sildenafil actually 
increase intracellular levels of cGMP or when it might increase in the course of ASI 
activation, it would be extremely valuable to be able to have a better reflection of 
intracellular cGMP levels of ASI. cGi500, a fluorescence-resonance-energy-transfer 
(FRET) based cGMP indicator will be introduced as a transgene into worm ASI using a 
gpa-4 promoter in various worm mutants and cGMP levels will be measured in different 
given conditions. Furthermore, rescue of the sildenafil phenotype of pde-5 mutants by 
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expressing pde-5 only in ASI using the gpa-4 promoter would confirm that the sildenafil 
effect we found is through ASI.    
To provide a better comparison between the ORO staining of wild-type worms 
and PDE mutants, wild-type worms and all PDE mutants will be treated with sildenafil 
and stained in one experiment to eliminate the possibility of variation in experimental 
conditions or staining. Furthermore, to more accurately mimic the intracellular conditions 
of PDE mutants, which do not have PDEs their entire lifetime, worms will be treated with 
sildenafil for their entire lifetime rather than only for 24 hours.  
To further elucidate the role of DAF-11 in ASI activation, there are several 
additional experiments that will be conducted. daf-11 mutants will be crossed with an 
integrated line of wild-type worms carrying the transgene to express GCaMP in ASI then 
homozygosed to reduce any variations coming from the copy number variation from the 
additional GCaMP transgene. In addition, to confirm that the 50% of reduction in ASI 
activation is due to the daf-11 mutation failing to produce cGMP, daf-11 mutants will be 
treated with 8-Br-cGMP and the ASI activation will be measured. If 8-Br-cGMP could 
activate ASI of daf-11 mutants more reliably than LB, it would show that the 50% of 
reduction in ASI activation in daf-11 mutants by LB is indeed due to the daf-11 function 
in nutrient sensing.  Short-term treatment with RNAi for DAF-11 in wild-type worms 
will also be used to eliminate the possibility of overall worm adaptation to the daf-11 
mutation. Also it is unclear whether the daf-11 mutation is a complete knockout in its 
function, so treatment with RNAi for DAF-11 of daf-11 mutants will be useful to do in 
order to completely block the formation of DAF-11. Finally, the origin of the intracellular 
	  
  34 
   
   
calcium will be traced in the ASI and neighboring neuron AIA, which connects to the 
ASI via gap junctions. If calcium originates from the neuron processes, then a different 
neuron may be relaying signals to ASI in order for it to activate. If calcium is originated 
from the cell body rather than the cell processes, ASI might be activated by action of 
AIA. It would be enlightening to see whether AIA has a role in ASI activation and may 
contribute to the biological redundancy of DAF-11, which could be why only mutating 
DAF-11 might not completely abolish ASI activation.  
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